- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Big Green Snowflakes
Global Pharmaceuticals & Biotech Big Green Snowflakes
Results
3048
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3048 companies
Inovio Pharmaceuticals
Market Cap: US$146.1m
A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
INO
US$2.79
7D
17.7%
1Y
-55.6%
Navamedic
Market Cap: NOK 381.5m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.60
7D
-0.5%
1Y
-22.0%
Guard Therapeutics International
Market Cap: SEK 459.8m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 22.80
7D
2.2%
1Y
-20.8%
Jiangsu Kanion PharmaceuticalLtd
Market Cap: CN¥9.7b
Researches and develops, produces, and sells Chinese medicines.
600557
CN¥17.09
7D
-0.06%
1Y
32.7%
Cutia Therapeutics
Market Cap: HK$3.7b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$10.50
7D
-9.1%
1Y
-19.2%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.9b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.25
7D
-0.8%
1Y
10.6%
Cenra
Market Cap: NT$5.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$34.00
7D
-0.4%
1Y
-11.2%
Bal Pharma
Market Cap: ₹1.4b
Manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.
524824
₹88.48
7D
1.4%
1Y
-34.0%
Hester Biosciences
Market Cap: ₹18.1b
Manufactures and trades in veterinary vaccines and animal health products in India and internationally.
524669
₹2,126.15
7D
5.0%
1Y
-12.2%
3D Global Biotech
Market Cap: NT$3.9b
Develops medical materials for human body reconstruction in China.
6808
NT$50.10
7D
0%
1Y
29.0%
Beijing Sun-Novo Pharmaceutical Research
Market Cap: CN¥8.4b
A contract research company, engages in the research and development of drugs in China.
688621
CN¥77.11
7D
4.9%
1Y
151.2%
Sunrest Lifescience
Market Cap: ₹211.1m
Engages in the trading, wholesale, and retail of pharmaceutical products in India.
SUNREST
₹49.20
7D
0%
1Y
-19.9%
Haw Par
Market Cap: S$3.2b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$14.29
7D
2.1%
1Y
36.7%
Akums Drugs and Pharmaceuticals
Market Cap: ₹70.5b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹460.20
7D
1.3%
1Y
-46.8%
Shilpa Medicare
Market Cap: ₹82.5b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹844.10
7D
-0.3%
1Y
4.4%
Inner Mongolia Furui Medical Science
Market Cap: CN¥17.1b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥64.35
7D
-1.0%
1Y
70.6%
Evotec
Market Cap: €1.0b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€5.86
7D
-2.4%
1Y
-1.4%
Soligenix
Market Cap: US$13.0m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$2.86
7D
-7.7%
1Y
-23.5%
Janux Therapeutics
Market Cap: US$1.4b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$23.98
7D
5.5%
1Y
-41.9%
Citius Pharmaceuticals
Market Cap: US$19.6m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$1.23
7D
-7.5%
1Y
-90.7%
Prestige Consumer Healthcare
Market Cap: US$3.3b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$65.05
7D
-4.4%
1Y
-12.5%
Cantargia
Market Cap: SEK 632.7m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 2.55
7D
-7.3%
1Y
-34.2%
ECO Animal Health Group
Market Cap: UK£49.8m
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.
EAH
UK£0.73
7D
0%
1Y
-37.4%
Zealand Pharma
Market Cap: DKK 31.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 448.00
7D
2.4%
1Y
-45.9%
VYNE Therapeutics
Market Cap: US$7.9m
A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.
VYNE
US$0.30
7D
-6.6%
1Y
-84.3%
Tectonic Therapeutic
Market Cap: US$323.2m
A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).
TECX
US$16.80
7D
-34.2%
1Y
-8.5%
Active Biotech
Market Cap: SEK 204.2m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.17
7D
-9.3%
1Y
-56.2%
Aardvark Therapeutics
Market Cap: US$184.2m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$8.60
7D
3.6%
1Y
n/a
Nykode Therapeutics
Market Cap: NOK 503.5m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.54
7D
0.1%
1Y
-70.2%
Molecular Partners
Market Cap: CHF 108.4m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 2.90
7D
0%
1Y
-39.2%
BioArctic
Market Cap: SEK 25.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 290.20
7D
-4.1%
1Y
59.5%
Lonza Group
Market Cap: CHF 40.6b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 577.40
7D
1.8%
1Y
7.7%
Evogene
Market Cap: ₪36.3m
Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
EVGN
₪4.17
7D
-4.8%
1Y
-63.4%
NovaBay Pharmaceuticals
Market Cap: US$21.7m
Does not have significant operations.
NBY
US$3.73
7D
109.6%
1Y
736.7%
Viking Therapeutics
Market Cap: US$3.0b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$26.98
7D
-0.3%
1Y
-50.2%
Ardelyx
Market Cap: US$1.6b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.52
7D
2.5%
1Y
16.4%